|Day Low/High||118.86 / 120.71|
|52 Wk Low/High||53.30 / 156.16|
Jim Cramer takes a closer look at DexCom, HCA Healthcare, Tractor Supply, Sarepta Therapeutics, The Blackstone Group, HNI Corp. and more.
Jim Cramer says it's the start CNBC's annual Stock Draft Contest, but he cautions Mad Money viewers that although investing can be fun, it requires discipline and doing your homework.
FNV, NOK, HBB, DXCM and MG all recently were downgraded by TheStreet's Quant Ratings.
TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,100 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: ESTE, PAGP, SJT, SPH, VOYA Downgrades: CPLG, DXCM, EVOL, FNV, RPM, TCPC Initiations: SECO, SPRO Read on to get TheStreet Quant Ratings' detailed report:
DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its first quarter 2019 financial results after market close on Wednesday, May 1, 2019.
Apple couldn't do much to hold back the bears today, but Jim Cramer says the company's services segment is the most important thing and he's more than happy with it.
What would the people who help determine AAPL's stock price really want?
The stock is just too expensive here ... unless the company buys these two medical-devices companies.
Disruptors are among the biggest winners, says Jim Cramer. Companies like Apple and Kraft Heinz need to re-imagine their companies in bold, meaningful and even radical ways.
In this day and age, companies must be 'disruptors' or get left in the dust.
Jim Cramer has your game plan for next week: Keep a sharp eye out for the Fed and the employment data.
DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on Dexcom at the following upcoming investor conference: Steven Pacelli, Executive Vice President, Strategy and Corporate Development, will present an update on the company...
DexCom, Inc. (Nasdaq: DXCM) today reported its financial results as of and for the quarter and fiscal year ended December 31, 2018.
DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its fourth quarter and full year 2018 financial results after market close on Thursday, February 21, 2019.
This will be the craziest reporting season we've seen in ages, says Jim Cramer. He's got your game plan for next week.
Jim Cramer takes a look at Take-Two Interactive, Sina, Cliffs Natural Resources, Public Service Enterprise, Annaly Capital, Neutral Tandem and more.
Jim Cramer says it looks like the bulls are no longer fighting the Fed or the tape.
You can't wait. You have to buy ahead of the end of bad news. Jim Cramer puts this market action in context.
DexCom, Inc. (Nasdaq: DXCM), the leader in continuous glucose monitoring ("CGM"), today reported that it expects preliminary, unaudited revenue for the fourth quarter ended December 31, 2018 to exceed $331 million, an increase of at least 50% over the...
DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on Dexcom at the following upcoming investor conference: Kevin Sayer, Chairman, Chief Executive Officer and President, will present an update on the company at the J.
DexCom, Inc. (Nasdaq: DXCM) ("DexCom") announced today that it intends to offer, subject to market conditions and other factors, $750 million aggregate principal amount of Convertible Senior Notes due 2023 (the "notes") in a private placement to qualified...
DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on Dexcom at the following upcoming investor conference: Steven Pacelli, Executive Vice President, Strategy and Corporate Development and Matthew Dolan, Vice President,...
DexCom, Inc. ( NASDAQ:DXCM), a leader in continuous glucose monitoring (CGM), and Verily, an Alphabet company, announced an amendment to the Collaboration and License Agreement surrounding the ongoing development efforts between the companies.
DexCom, Inc. (NASDAQ:DXCM) today announced that it will host an Investor Day on December 4, 2018 at the Laguna Cliffs Marriott in Dana Point, California.
DexCom, Inc. (Nasdaq: DXCM) today reported its unaudited financial results as of and for the quarter ended September 30, 2018.
Jim Cramer, celebrating the opening of the NFL season, says this is just another day of total tech mayhem.
Jim Cramer takes a closer look at PayPal, Senseonomics, Idexx Laboratories, Sonos, Denbury Resources, Apptio, Invitae, Wayfair, JD.com, and McDonald's.
Jim Cramer says Wall Street isn't very worried about tariffs. He highlights the stocks with China exposure and looks at the potential impact.
TheStreet’s Fundamentals of Investing Course will teach you the keys to making the right decisions in any market.
TheStreet’s Personal Finance Essentials Course will teach you money management basics and investing strategies to help you avoid major financial pitfalls.
TheStreet Courses offers dedicated classes designed to improve your investing skills, stock market knowledge and money management capabilities.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.